Education - Career Ladder - National Board Certification Associated Salary Increases
Summary
HB1115 would increase and formalize state support for the Maryland Pediatric Cancer Fund. It requires the Governor, beginning in fiscal year 2027, to include a $5 million appropriation to the Fund in the annual budget bill each year, and it expands the Fund’s revenue sources to include money from the Cigarette Restitution Fund. The bill also makes corresponding changes to the Cigarette Restitution Fund statute so that up to $5 million may be appropriated to the Pediatric Cancer Fund each year starting in fiscal year 2027.
The bill keeps the Fund limited to pediatric cancer research and related administrative costs, while allowing up to 5% of the Fund to be used for promotion, outreach, and administration. It continues to require grants to eligible physicians, hospitals, laboratories, educational institutions, and other entities for pediatric cancer research, and it bars use of grant money for general overhead or unrelated expenses. The Secretary of Health must report annually to the General Assembly and adopt regulations for the grant program.
Impact
HB1115 would amend the Health - General Article and the State Finance and Procurement Article to create a more durable funding stream for pediatric cancer research. It shifts the Maryland Pediatric Cancer Fund from relying primarily on direct budget appropriations and donations to also receiving support from the Cigarette Restitution Fund, and it authorizes the Governor to include a dedicated annual appropriation from that fund beginning in fiscal 2027. The bill would therefore affect how cigarette settlement dollars may be allocated and would add a new recurring budget obligation tied to pediatric cancer research.
Sentiment
Based on the bill text and the absence of recorded committee testimony or votes in the provided materials, the bill appears to be framed positively as a targeted public health and research funding measure. Its structure suggests broad support for pediatric cancer research and for creating a stable funding source. No contrary positions are documented in the supplied context, so there is no clear evidence of organized opposition or divided sentiment in the available record.
Contention
The main policy issue is funding source and budget priority. The bill redirects or authorizes use of Cigarette Restitution Fund dollars for the Pediatric Cancer Fund, which could raise concerns about competition with other uses of tobacco settlement money, including tobacco prevention, Medicaid, cancer prevention and treatment, and other public health programs. Another possible point of discussion is the size and timing of the required appropriation: the bill mandates $5 million annually beginning in fiscal 2027, which may be viewed as a significant recurring commitment even though it is limited to a specific research purpose. No specific objections or supporters are identified in the provided transcripts or votes.